The burden of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB
This infographic shows the burden in the EU of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB based on data from the 2014 surveillance report
Tuberculosis - Annual Epidemiological Report, 2016 [2014 data]
In 2014, 58 008 cases of TB were reported in 29 EU/EEA countries (Table 1). As in previous years, three countries (Poland, Romania and the United Kingdom) accounted for approximately 50% of all reported cases, with Romania alone accounting for 27%.
Key messages - Drug-resistant tuberculosis
TB is slowly declining but MDR and XDR TB pose a serious challenge in the attempt to eliminate TB across Europe.
Tuberculosis surveillance and monitoring in Europe, 2018
The Annual TB Surveillance and Monitoring report presents the key figures and trends and provides an overview of the TB situation in the EU/EEA and the WHO European Region.
Healthcare system factors influencing treatment results of patients with multidrug-resistant tuberculosis
Qualitative research was carried out in four EU countries to try to identify the factors of a healthcare system that are key to achieving good treatment results for patients with multidrug-resistant tuberculosis.
Tuberculosis surveillance and monitoring in Europe 2016
The eighth report launched jointly by ECDC and the WHO Regional Office for Europe indicates that, despite notable progress in the past decade, tuberculosis (TB) is still a public health concern in many countries across Europe.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA – January 2016
This report describes the geographical and temporal distribution of multidrug-resistant tuberculosis based on molecular typing data (24-locus MIRU–VNTR genotyping) as reported by EU/EEA countries.